{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:34:26Z","timestamp":1789598066131,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS056872"],"award-info":[{"award-number":["R01 NS056872"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 RR027552"],"award-info":[{"award-number":["S10 RR027552"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-1-0190"],"award-info":[{"award-number":["W81XWH-12-1-0190"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.nbd.2015.04.016","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T07:39:10Z","timestamp":1432193950000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex"],"prefix":"10.1016","volume":"80","author":[{"given":"Bo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Rensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.04.016_bb0005","doi-asserted-by":"crossref","first-page":"e101477","DOI":"10.1371\/journal.pone.0101477","article-title":"Is peripheral immunity regulated by blood\u2013brain barrier permeability changes?","volume":"9","author":"Bargerstock","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.04.016_bb0010","doi-asserted-by":"crossref","first-page":"9056","DOI":"10.1523\/JNEUROSCI.3870-12.2013","article-title":"PI3K\u2013Akt signaling activates mTOR-mediated epileptogenesis in organotypic hippocampal culture model of post-traumatic epilepsy","volume":"33","author":"Berdichevsky","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.04.016_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2007.10.002","article-title":"Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex","volume":"78","author":"Boer","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2015.04.016_bb0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1750-3639.2009.00341.x","article-title":"Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors","volume":"20","author":"Boer","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0025","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.04.016_bb0030","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2015.04.016_bb0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/cyto.2000.0837","article-title":"The effects of phenolic components of tea on the production of pro- and anti-inflammatory cytokines by human leukocytes in vitro","volume":"13","author":"Crouvezier","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.nbd.2015.04.016_bb0040","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1046\/j.1460-9568.2000.00140.x","article-title":"Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus","volume":"12","author":"De Simoni","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2015.04.016_bb0045","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1528-1167.2007.01110.x","article-title":"The natural history and treatment of epilepsy in a murine model of tuberous sclerosis","volume":"48","author":"Erbayat-Altay","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.04.016_bb0055","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte\u2013endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2015.04.016_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2010.05.016","article-title":"The emerging role for chemokines in epilepsy","volume":"224","author":"Fabene","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomized, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2015.04.016_bb0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1073\/pnas.1106454108","article-title":"Regulable neural progenitor-specific TSC1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex","volume":"108","author":"Goto","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.04.016_bb0070","doi-asserted-by":"crossref","first-page":"e64078","DOI":"10.1371\/journal.pone.0064078","article-title":"Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.04.016_bb0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous Sclerosis Complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.04.016_bb0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jnutbio.2009.04.005","article-title":"Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts","volume":"21","author":"Hosokawa","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.nbd.2015.04.016_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2010.05.024","article-title":"Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.04.016_bb0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/brain\/awl317","article-title":"TFG-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis","volume":"130","author":"Ivens","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.04.016_bb0095","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1528-1167.2005.00289.x","article-title":"Epileptogenesis and reduced inward rectifier potassium current in Tuberous Sclerosis Complex-1 deficient astrocytes","volume":"46","author":"Jansen","year":"2005","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1016\/j.nbd.2015.04.016_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1528-1167.2012.03701.x","article-title":"Blood\u2013brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis","volume":"53","author":"Kim","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.04.016_bb0105","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in Tuberous Sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2015.04.016_bb0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.seizure.2010.12.005","article-title":"Cytokines and epilepsy","volume":"20","author":"Li","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.nbd.2015.04.016_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0969-9961(03)00127-X","article-title":"Expression of ICAM-1, TNF-\u03b1, NF\u03baB, and MAP kinase in tubers of the tuberous sclerosis complex","volume":"14","author":"Maldonado","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.04.016_bb0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2008.10.002","article-title":"Antagonism of peripheral inflammation reduces the severity of status epilepticus","volume":"33","author":"Marchi","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.04.016_bb0135","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","article-title":"Blood\u2013brain barrier dysfunction and epilepsy: pathophysiologic roles and therapeutic approaches","volume":"53","author":"Marchi","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.04.016_bb0125","doi-asserted-by":"crossref","first-page":"e56805","DOI":"10.1371\/journal.pone.0056805","article-title":"Consequences of repeated blood\u2013brain barrier disruption in football players","volume":"8","author":"Marchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.04.016_bb0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","article-title":"Interleukin-1\u03b2 biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice","volume":"8","author":"Maroso","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2015.04.016_bb0145","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of Tuberous Sclerosis to mammalian target of Rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.04.016_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2015.04.016_bb0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1750-3639.2012.00616.x","article-title":"Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation","volume":"23","author":"Prabowo","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","article-title":"Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy","volume":"29","author":"Ravizza","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.04.016_bb0170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nbd.2008.05.007","article-title":"Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1\u03b2 production","volume":"31","author":"Ravizza","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.04.016_bb0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eplepsyres.2009.09.004","article-title":"Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability","volume":"89","author":"Riazi","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2015.04.016_bb0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0185","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1528-1167.2012.03513.x","article-title":"Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood\u2013brain barrier leakage but not microglia activation","volume":"53","author":"van Vliet","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.04.016_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.04.016_bb0210","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.it.2009.02.002","article-title":"The multiple facets of mTOR in immunity","volume":"30","author":"Weicchart","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1528-1167.2007.01270.x","article-title":"Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation","volume":"49","author":"Wong","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.04.016_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.04.016_bb0225","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/ern.13.48","article-title":"A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials","volume":"13","author":"Wong","year":"2013","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.nbd.2015.04.016_bb0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.10648","article-title":"Impaired astrocyte glutamate transport in a mouse epilepsy model of tuberous sclerosis complex","volume":"54","author":"Wong","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nbd.2009.01.010","article-title":"Impaired astrocyte gap junction coupling and potassium buffering in a mouse model of Tuberous Sclerosis Complex","volume":"34","author":"Xu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.04.016_bb0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fncel.2013.00195","article-title":"Immune mechanisms in epileptogenesis","volume":"7","author":"Xu","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2015.04.016_bb0235","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.04.016_bb0240","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.04.016_bb0245","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/hmg\/ddq491","article-title":"TSC2 gene inactivation causes a more severe epilepsy phenotype than TSC1 inactivation in a mouse model of Tuberous Sclerosis Complex","volume":"20","author":"Zeng","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.04.016_bb0250","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0028-3908(01)00174-5","article-title":"Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents","volume":"42","author":"Zhang","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.04.016_bb0255","doi-asserted-by":"crossref","first-page":"e92698","DOI":"10.1371\/journal.pone.0092698","article-title":"Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:09:28Z","timestamp":1760850568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":50,"alternative-id":["S0969996115001722"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.04.016","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}